FindTrial
Sign In

Radio-controlled surgery RGS in the gastric carcinoma locally advanced subordinate to neoadiuvante medical therapy. Clinical study of feasibilities and correlation with the traditional methodical of restaging presurgical - ND

Radio-controlled surgery RGS in the gastric carcinoma locally advanced subordinate to neoadiuvante medical therapy. Clinical study of feasibilities and correlation with the traditional methodical of restaging presurgical - ND

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2006-001500-36-IT
Enrollment
20
Registered
2006-06-05
Start date
2006-05-12
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

carcinoma of the locally advanced stomach MedDRA version: 6.1 Level: PT Classification code 10017758

Interventions

Product Name: Nanocoll Pharmaceutical Form: Powder for infusion* INN or Proposed INN: Technetium 99mTc human albumin Concentration unit: MBq megabecquerel(s) Concentration type: equal Concentration

Sponsors

AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Patients with locally advanced gastric carcinoma subordinates to adjuvant medical therapy with the regimen employed near the oncological structure of reference. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: - All inoperableconditions - Presence of metastasis

Design outcomes

Primary

MeasureTime frame
Main Objective: To demonstrate the high effectiveness, accuracy and sensibility of the technology of the radioisotopes confronting it with the current technical of imaging for the stage preoperative after newadjuvant therapy.;Secondary Objective: Comparazione between appraisal of the radio-controlled surgery and histophatological characterization;Primary end point(s): Validation of the method for a more corrected approach to the gastric cancer in locally advanced phase—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026